Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nanexa | NANEXA | Apr 30, 2024 | 0.70 | +12.90 |
NanoCap Group B | NANOCB | Apr 30, 2024 | 8.54 | -0.47 |
Nanoform Finland | NANOFS | Apr 30, 2024 | 25.60 | -0.78 |
Nanologica | NICA | Apr 30, 2024 | 5.70 | +1.06 |
NASDAQ OMX Small Cap Sweden GI | NOMXSCSEGI | Apr 30, 2024 | 4 185.30 | +0.40 |
NASDAQ OMX Small Cap Sweden PI | NOMXSCSE | Apr 30, 2024 | 2 613.51 | +0.34 |
Nattaro Labs | NATTA | Apr 30, 2024 | 0.73 | 0.00 |
Navigo Invest AB | NAVIGOSTAM | Apr 30, 2024 | 4.50 | -0.22 |
Navigo Invest Pref | NAVIGOPREF | Apr 30, 2024 | 106.50 | 0.00 |
NAXS | NAXS | Apr 30, 2024 | 65.00 | -0.61 |
NCAB Group | NCAB | Apr 30, 2024 | 72.55 | +0.14 |
NCC A | NCCA | Apr 30, 2024 | 135.00 | +0.75 |
NCC B | NCCB | Apr 30, 2024 | 135.10 | +0.60 |
Nederman Holding | NMAN | Apr 30, 2024 | 190.80 | -0.10 |
NEL | NELO | Apr 30, 2024 | 5.19 | -0.31 |
Nelly Group | NELLY | Apr 30, 2024 | 17.58 | -0.57 |
Neobo Fastigheter | NEOBO | Apr 30, 2024 | 15.86 | +0.32 |
NeoDynamics | NEOD | Apr 30, 2024 | 0.95 | -0.21 |
Neola Medical | NEOLA | Apr 30, 2024 | 2.08 | 0.00 |
Nepa | NEPA | Apr 30, 2024 | 27.90 | -0.36 |
Net Insight B | NETIB | Apr 30, 2024 | 5.25 | -1.87 |
Netel | NETEL | Apr 30, 2024 | 15.08 | -0.66 |
NetJobs Group | NJOB | Apr 30, 2024 | 0.28 | -11.32 |
New Nordic Healthbrands | NNH | Apr 30, 2024 | 18.80 | -6.93 |
New Wave B | NEWAB | Apr 30, 2024 | 101.90 | -0.97 |
Newbury Pharmaceuticals | NEWBRY | Apr 30, 2024 | 3.41 | 0.00 |
News55 | N55 | Apr 30, 2024 | 2.60 | 0.00 |
Nexam Chemical Holding | NEXAM | Apr 30, 2024 | 3.14 | +4.32 |
Nexar Group | NXAR | Apr 30, 2024 | 0.22 | -1.75 |
NextCell Pharma AB | NXTCL | Apr 30, 2024 | 1.34 | +1.13 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.